Jaynelle Gao

2 days ago | onlinelibrary.wiley.com | Jaynelle Gao |Ryan Chung |Jason Chwa |Kevin Hur

1 Introduction Immune checkpoint inhibitors (ICIs), which suppress immune checkpoint receptor-ligand binding to promote T-cell activation and antitumor immunity [1], have been increasingly utilized in recent years, becoming the standard of care for approximately 8% of head and neck cancers in 2020 [1-3].

Apr 30, 2024 | medrxiv.org | Jane Zebrack |Jaynelle Gao |Lu Tian |Britta Verhey

The authors have declared no competing interest. This study did not receive any grant support but rather was funded by philanthropy through foundations. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Stanford University Institutional Review Board gave ethical approval for this work.